Acrobiosystems Co.,Ltd. (SHE:301080)

China flag China · Delayed Price · Currency is CNY
50.08
-0.62 (-1.22%)
At close: Feb 13, 2026
Market Cap8.35B +42.5%
Revenue (ttm)794.52M +33.6%
Net Income172.77M +58.6%
EPS1.03 +58.4%
Shares Out166.73M
PE Ratio48.66
Forward PE33.17
Dividend0.57 (1.13%)
Ex-Dividend Daten/a
Volume3,292,485
Average Volume3,795,595
Open50.32
Previous Close50.70
Day's Range50.01 - 51.97
52-Week Range26.00 - 71.49
Beta0.95
RSI36.74
Earnings DateApr 21, 2026

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301080
Full Company Profile

Financial Performance

In 2024, Acrobiosystems's revenue was 645.02 million, an increase of 18.65% compared to the previous year's 543.65 million. Earnings were 123.83 million, a decrease of -19.38%.

Financial Statements